TRLV
Trulieve Cannabis Corp.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+27/100
Last price
10.65
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
10.65
Day high
10.83
Day low
10.42
Volume
1.16M
Market cap
$2.05B
P/E (TTM)
—
52W range
4.62 – 13.28
Trailing performance
Returnvs SPY
1W
-14.18%
-16.1%
1M
-12.06%
-13.2%
3M
+19.80%
+15.3%
6M
+76.91%
+58.7%
YTD
+22.55%
+8.3%
1Y
+25.12%
+8.7%
3Y
+74.88%
-7.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TRLV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+10.64M
Net buying
Buy transactions
112
12.34M shares
Sell transactions
4
1.70M shares
Net transactions
+116
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
2.37M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 26, 26 | RIVERS KIMBERLY A Chief Executive Officer |
SELL | 136.81K | $1.20M | Direct |
| Jun 25, 26 | RIVERS KIMBERLY A Chief Executive Officer |
SELL | 1.08M | $8.94M | Direct |
| Jun 22, 26 | RIVERS KIMBERLY A Chief Executive Officer |
SELL | 482.20K | $4.53M | Direct |
| Mar 13, 26 | JHALA NILYUM Chief Technology Officer |
— | 58.59K | — | Direct |
| Mar 13, 26 | PERNELL JASON BARRY President |
— | 58.59K | — | Direct |
| Mar 13, 26 | REESE JAN Chief Financial Officer |
— | 58.59K | — | Direct |
| Mar 13, 26 | HERSEY CHRISTINE ANN Officer |
— | 58.59K | — | Direct |
| Mar 13, 26 | WALSH BRETT Officer |
— | 28.71K | — | Direct |
| Mar 13, 26 | MILLNER THOMAS L Director |
— | 23.44K | — | Direct |
| Mar 13, 26 | MORREAU JANE CECIL Director |
— | 23.44K | — | Direct |
| Mar 13, 26 | THRONSON SUSAN E Director |
— | 23.44K | — | Direct |
| Mar 13, 26 | FOULSTON MATTHEW JOHN Director |
— | 23.44K | — | Direct |
| Mar 13, 26 | BESHEARS THAD Director |
— | 23.44K | — | Direct |
| Mar 13, 26 | POWERS RAYMOND ERIC III Officer |
— | 58.59K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BESHEARS THAD |
Director | 2.49M | Stock Award(Grant) |
COLLINS GINA |
Officer | 188.92K | Stock Award(Grant) |
HERSEY CHRISTINE ANN |
Officer | 143.77K | Stock Award(Grant) |
JHALA NILYUM |
Chief Technology Officer | 246.25K | Stock Award(Grant) |
LANDRUM KYLE FINN |
Officer | 258.78K | Stock Award(Grant) |
MAY RICHARD SUBER |
Director | 593.53K | Stock Award(Grant) |
MOREY TIMOTHY J. |
Officer | 191.45K | Stock Award(Grant) |
PERNELL JASON BARRY |
President | 581.79K | Stock Award(Grant) |
POWERS RAYMOND ERIC III |
Officer | 246.31K | Stock Award(Grant) |
RIVERS KIMBERLY A |
Chief Executive Officer | 1.48M | Sale |
Fundamentals
Market cap$2.05B
Enterprise value$2.30B
Revenue (TTM)$1.14B
Gross profit$677.39M
EBITDA$301.02M
Net income$-467.83M
EPS (TTM)$-2.43
Free cash flow$232.04M
Total cash$325.42M
Total debt$577.87M
Book value / share$6.07
Shares outstanding170.16M
Float167.89M
Short % of float3.08%
Dividend yield0.00%
Beta (5Y)1.81
Valuation & profitability ratios
Trailing P/E—
Forward P/E19.13
PEG ratio—
Price / sales—
Price / book1.75
EV / revenue2.02
EV / EBITDA7.65
Gross margin59.47%
Operating margin12.84%
Profit margin-41.55%
Return on equity-47.65%
Return on assets3.28%
Debt / equity75.45
Current ratio5.94
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.18B | $1.19B | $1.13B | $1.22B | -0.4% |
| Operating revenue | $1.18B | $1.19B | $1.13B | $1.22B | -0.4% |
| Cost of revenue | $470.01M | $470.75M | $540.57M | $529.10M | -0.2% |
| Gross profit | $711.17M | $715.75M | $588.63M | $689.13M | -0.6% |
| Selling, general & admin | $445.21M | $510.45M | $386.16M | $447.03M | -12.8% |
| Total operating expense | $562.85M | $623.26M | $495.99M | $563.41M | -9.7% |
| Operating income | $148.32M | $92.49M | $92.64M | $125.71M | +60.4% |
| Net interest income | -$48.93M | -$47.52M | -$75.41M | -$71.79M | -3.0% |
| Pre-tax income | $91.47M | $42.71M | -$284.54M | -$19.24M | +114.2% |
| Tax provision | $208.11M | $197.59M | $151.36M | $163.38M | +5.3% |
| Net income | -$116.38M | -$155.10M | -$526.80M | -$246.06M | +25.0% |
| Net income to common | -$116.38M | -$155.10M | -$526.80M | -$246.06M | +25.0% |
| Basic EPS | -0.61 | -0.82 | -2.79 | -1.31 | +25.6% |
| Diluted EPS | -0.61 | -0.82 | -2.79 | -1.31 | +25.6% |
| EBIT | $154.93M | $104.91M | -$202.97M | $54.18M | +47.7% |
| EBITDA | $328.33M | $271.28M | -$32.31M | $239.75M | +21.0% |
| Basic shares | 191.30M | 190.00M | 188.97M | 188.00M | +0.7% |
| Diluted shares | 191.30M | 190.00M | 188.97M | 188.00M | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $255.53M | $238.80M | $201.37M | $207.19M | +7.0% |
| Cash & short-term investments | $255.53M | $299.20M | $201.37M | $207.19M | -14.6% |
| Accounts receivable | $10.50M | $8.29M | $6.70M | $6.51M | +26.7% |
| Inventory | $242.30M | $231.37M | $213.12M | $276.50M | +4.7% |
| Total current assets | $562.72M | $604.56M | $477.35M | $593.54M | -6.9% |
| Property, plant & equipment | $838.74M | $899.98M | $830.80M | $912.68M | -6.8% |
| Goodwill & intangibles | $1.28B | $1.34B | $1.40B | $1.78B | -4.5% |
| Total assets | $2.70B | $2.87B | $2.73B | $3.40B | -6.1% |
| Total current liabilities | $126.94M | $138.49M | $114.85M | $210.29M | -8.3% |
| Current debt | $4.08M | $3.41M | $3.76M | $12.45M | +19.7% |
| Long-term debt | $227.58M | $476.78M | $479.07M | $635.91M | -52.3% |
| Total debt | $563.62M | $824.46M | $792.57M | $975.06M | -31.6% |
| Total liabilities | $1.55B | $1.62B | $1.32B | $1.47B | -4.2% |
| Retained earnings | -$912.13M | -$795.74M | -$640.64M | -$113.84M | -14.6% |
| Shareholder equity | $1.16B | $1.26B | $1.41B | $1.93B | -7.9% |
| Working capital | $435.77M | $466.06M | $362.50M | $383.25M | -6.5% |
| Net tangible assets | -$121.04M | -$82.10M | $13.38M | $154.87M | -47.4% |
| Shares issued | 192.31M | 191.01M | 186.24M | 185.99M | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$122.25M | -$160.58M | -$533.14M | -$252.73M | — | +23.9% |
| Depreciation & amortisation | $173.40M | $166.37M | $170.66M | $185.57M | — | +4.2% |
| Stock-based compensation | $20.47M | $20.20M | $10.57M | $18.12M | — | +1.3% |
| Change in working capital | $188.17M | $234.88M | $173.56M | -$32.71M | — | -19.9% |
| Operating cash flow | $272.82M | $271.48M | $201.84M | $23.10M | — | +0.5% |
| Capital expenditure | -$60.51M | -$147.66M | -$50.85M | -$193.80M | — | +59.0% |
| Investing cash flow | $13.50M | -$206.62M | -$37.47M | -$215.06M | — | +106.5% |
| Dividends paid | — | — | -$50.00K | -$50.00K | $0 | — |
| Financing cash flow | -$270.50M | -$33.44M | -$175.59M | $177.80M | — | -708.9% |
| Free cash flow | $212.31M | $123.82M | $150.99M | -$170.70M | — | +71.5% |
| End cash position | $255.53M | $239.71M | $207.98M | $213.79M | — | +6.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $270.95M | $286.75M | $293.15M | $288.19M | $302.09M | -5.5% |
| Operating revenue | $270.95M | $286.75M | $293.15M | $288.19M | $302.09M | -5.5% |
| Cost of revenue | $108.66M | $116.67M | $117.98M | $118.33M | $119.16M | -6.9% |
| Gross profit | $162.29M | $170.08M | $175.16M | $169.86M | $182.93M | -4.6% |
| Selling, general & admin | $101.77M | $104.89M | $126.31M | $99.02M | $101.12M | -3.0% |
| Total operating expense | $127.49M | $134.64M | $155.73M | $128.47M | $130.54M | -5.3% |
| Operating income | $34.80M | $35.44M | $19.44M | $41.38M | $52.38M | -1.8% |
| Net interest income | -$9.70M | -$10.64M | -$11.26M | -$11.69M | -$12.76M | +8.8% |
| Pre-tax income | -$383.40M | $25.22M | $2.94M | $29.30M | $38.90M | -1,620.2% |
| Tax provision | $21.97M | $21.86M | $47.89M | $53.04M | $54.72M | +0.5% |
| Net income | -$405.98M | $2.41M | -$42.90M | -$26.84M | -$13.78M | -16,973.4% |
| Net income to common | -$405.98M | $2.41M | -$49.86M | -$21.79M | -$13.78M | -16,973.4% |
| Basic EPS | -2.10 | 0.01 | -0.22 | -0.14 | -0.07 | -21,100.0% |
| Diluted EPS | -2.10 | 0.01 | -0.22 | -0.14 | -0.07 | -21,100.0% |
| EBIT | -$370.64M | $38.54M | $17.62M | $45.39M | $55.30M | -1,061.7% |
| EBITDA | -$331.48M | $82.27M | $61.29M | $88.79M | $98.45M | -502.9% |
| Basic shares | 192.70M | 192.54M | 191.70M | 191.20M | 191.20M | +0.1% |
| Diluted shares | 192.70M | 197.76M | 191.70M | 191.20M | 191.20M | -2.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $325.42M | $352.88M | $255.53M | $449.20M | $392.58M | -7.8% |
| Cash & short-term investments | $325.42M | $352.88M | $255.53M | $449.20M | $392.58M | -7.8% |
| Accounts receivable | $3.94M | $14.05M | $10.50M | $10.49M | $10.76M | -72.0% |
| Inventory | $186.87M | $242.32M | $242.30M | $243.29M | $241.46M | -22.9% |
| Total current assets | $564.83M | $652.96M | $562.72M | $756.45M | $711.38M | -13.5% |
| Property, plant & equipment | $724.88M | $851.97M | $838.74M | $865.61M | $881.14M | -14.9% |
| Goodwill & intangibles | $626.07M | $1.26B | $1.28B | $1.30B | $1.32B | -50.5% |
| Total assets | $2.08B | $2.78B | $2.70B | $2.94B | $2.92B | -25.3% |
| Total current liabilities | $95.06M | $124.16M | $126.94M | $124.13M | $123.84M | -23.4% |
| Current debt | $4.18M | $4.15M | $4.08M | $3.74M | $3.67M | +0.8% |
| Long-term debt | $285.21M | $285.74M | $227.58M | $473.79M | $474.20M | -0.2% |
| Total debt | $577.26M | $628.70M | $563.62M | $813.06M | $823.70M | -8.2% |
| Total liabilities | $1.31B | $1.63B | $1.55B | $1.76B | $1.71B | -19.7% |
| Retained earnings | -$1.32B | -$909.72M | -$912.13M | -$869.23M | -$842.39M | -44.6% |
| Shareholder equity | $767.46M | $1.17B | $1.16B | $1.20B | $1.23B | -34.3% |
| Working capital | $469.77M | $528.80M | $435.77M | $632.31M | $587.55M | -11.2% |
| Net tangible assets | $141.40M | -$96.88M | -$121.04M | -$95.41M | -$91.23M | +246.0% |
| Shares issued | 192.38M | 192.31M | 192.31M | 191.14M | 191.10M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$406.06M | $2.28M | -$43.59M | -$28.78M | -$16.11M | -17,886.3% |
| Depreciation & amortisation | $39.15M | $43.73M | $43.67M | $43.41M | $43.15M | -10.5% |
| Stock-based compensation | $6.91M | $4.14M | $3.98M | $5.79M | $6.76M | +67.1% |
| Change in working capital | $11.84M | $10.85M | $51.63M | $54.38M | $46.53M | +9.1% |
| Operating cash flow | $53.14M | $55.71M | $59.22M | $76.38M | $86.09M | -4.6% |
| Capital expenditure | -$21.01M | -$13.48M | -$6.99M | -$16.72M | -$16.01M | -55.8% |
| Investing cash flow | -$74.86M | -$13.19M | -$5.89M | -$14.99M | -$8.63M | -467.6% |
| Financing cash flow | -$5.74M | $54.83M | -$255.39M | -$4.77M | -$5.83M | -110.5% |
| Free cash flow | $32.13M | $42.22M | $52.23M | $59.66M | $70.08M | -23.9% |
| End cash position | $325.42M | $352.88M | $255.53M | $457.61M | $400.99M | -7.8% |
Options analytics
Put / call volume
0.31
Call-heavy session
Put / call open interest
0.08
Positioning, not flow
Max pain
10.00
-6.1% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-12.5%
Calls bid over puts
Call volume
64
Contracts, this expiry
Put volume
20
Contracts, this expiry
Heaviest call OI
15.00
2.76K contracts
Heaviest put OI
10.00
353 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.03 | 0.11 | +266.7% |
| Mar 2026 | -0.05 | 0.10 | +300.0% |
| Dec 2025 | -0.03 | -0.02 | +31.0% |
| Sep 2025 | -0.07 | -0.07 | -3.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.07 | 2 | $221.63M | -23.1% |
| Next quarter | 0.08 | 2 | $229.47M | -21.7% |
| Current year | -1.82 | 5 | $1.01B | -14.6% |
| Next year | 0.56 | 3 | $936.36M | -7.2% |
Analyst targets & ownership
Mean target$18.18
High target$21.00
Low target$15.00
Implied upside70.69%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy1 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders1.23%
Held by institutions21.73%
Institutions holding137
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11.56
-7.84% from price
SMA 20
11.57
-7.96% from price
SMA 50
10.69
-0.33% from price
SMA 100
9.92
+7.38% from price
SMA 200
8.63
+23.46% from price
EMA 12
11.30
-5.75% from price
EMA 26
11.30
-5.79% from price
EMA 50
10.86
-1.91% from price
RSI (14)
41.2
Neutral
MACD (12,26,9)
-0.01
Hist -0.24
ATR (14)
0.79
7.41% of price
Realised vol 30D
59.8%
Annualised
Bollinger upper
12.82
20, 2σ
Bollinger lower
10.33
20, 2σ
50 / 200 cross
Golden
10.69 vs 8.63
Trend bias
Above 200
+23.46%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.03
More volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
59.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-54.4%
Peak to trough
Max drawdown 5Y
-89.6%
Peak to trough
ATR 14
0.79
7.41% of price
Beta (reported)
1.81
5Y monthly, from filing
Short interest
Shares short
5.12M
Prior 1.34M
Change vs prior
+283.3%
Shorts adding
% of float
3.08%
Normal
% of shares out
2.66%
Against total outstanding
Days to cover
3.3
Liquid
Float
167.89M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jul 20, 26 | Cantor Fitzgerald | INITIATED | — | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F- 3ASR
POSASR · 2026-08-24
Corporate Changes & Voting Matters
8-K · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-07-02
Proxy Statements
DEF 14A · 2026-06-25
Proxy Statements
PRE 14A · 2026-06-12
Corporate Changes & Voting Matters
8-K · 2026-06-11
Headlines
Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026
PR Newswire · 23h ago
Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026
CNW Group · 23h ago
2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors
Motley Fool · 4d ago
Trulieve Cannabis (TRLV) Falls On Rescheduling Delay, Is It Now A Bargain?
Simply Wall St. · 6d ago
Cannabis Investors Were Betting On Washington, Then Washington Hit Pause
Moby · 7d ago
Cannabis Stocks Are Slumping. A Procedural DEA Delay Is to Blame.
Barrons.com · 7d ago
Trulieve Sinks 14% as DEA Judge Pauses Cannabis Rescheduling Over GAO Report Flagging “Gaps”
TIKR · 7d ago
MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case
Stocktwits · 7d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.